Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.60 |
| ▸ | RAB9A | P51151 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.41 |
| ▸ | TLR4 | O00206 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906539 | 1.00 | NPC1 (0.60) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL30988355 | 1.00 | NPC1 (0.60) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL1907996 | 0.83 | MEN1 (0.64) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL1981293 | 0.83 | MEN1 (0.64) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL30988354 | 0.83 | MEN1 (0.64) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| Dipyridyl SCHEMBL28723689 | 0.79 | KDM4E (0.59) | NPC1RAB9AALDH1A1MAPTKDM4E | |
| SCHEMBL9347247 | 0.79 | KDM4E (0.56) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL6797384 | 0.79 | CYP19A1 (0.63) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL4712207 | 0.79 | NPC1 (0.58) | NPC1RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL9131383 | 0.79 | KDM1A (0.61) | NPC1RAB9AALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | L'OREAL (FR) | 2022-06-28 | — | — | US | disclosed |
| US-20220087920-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | L'OREAL (FR) | 2022-03-24 | — | — | US | disclosed |
| CN-108367167-B | Method for treating keratin materials using a composition comprising a modified photodimerisable polymer | 莱雅公司 | 2021-12-31 | — | — | CN | disclosed |
| EP-3897858-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | L'OREAL (FR) | 2021-10-27 | — | — | EP | disclosed |
| CN-113195058-A | Composition comprising a modified photodimerisable polymer and an alkaline agent and/or an aminoalkoxysilane derivative and treatment process for implementing the composition | 莱雅公司 | 2021-07-30 | — | — | CN | disclosed |
| EP-3393592-B1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | OREAL (FR) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020127230-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | L'OREAL (FR) | 2020-06-25 | — | — | WO | disclosed |
| US-20190000743-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | L'OREAL (FR) | 2019-01-03 | — | — | US | disclosed |
| EP-3393592-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | L'OREAL (FR) | 2018-10-31 | — | — | EP | disclosed |
| WO-2017108767-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | L'OREAL (FR) | 2017-06-29 | — | — | WO | disclosed |
| US-5559144-A | LIPOXYGENASE INHIBITORS, INHIBITORS OF BIOSYNTHESIS OF LEUKOTRIENES | ABBOTT LABORATORIES (US) | 1996-09-24 | — | — | US | disclosed |
| US-5476873-A | Inhibit biosynthesis of leukotrienes | ABBOTT LABORATORIES (US) | 1995-12-19 | — | — | US | disclosed |
| EP-0540673-A4 | — | — | 1994-04-27 | — | — | EP | disclosed |
| US-5234946-A | Anticholesterol, antilipemic | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | disclosed |
| EP-0318860-B1 | SUBSTITUTED ALKYLAMINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0540673-A1 | ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY. | ABBOTT LAB (US) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992001682-A1 | ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LABORATORIES (US) | 1992-02-06 | — | — | WO | disclosed |
| CN-1037141-A | The alkylamine derivative that replaces | BANYU PHARMA CO LTD (JP) | 1989-11-15 | — | — | CN | disclosed |
| EP-0318860-A2 | Substituted alkylamine derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
| US-4272620-A | Polyvinyl alcohol-styrylpyridinium photosensitive resins and method for manufacture thereof | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1981-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190000743-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | KRT18, KRTCAP2, CKAP4 | NPC1 4815/4885RAB9A 3881/4885ALDH1A1 1833/4885 |
| US-20220087920-A1 | COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION | ACP1, ALAD, PHOSPHO1 | NPC1 4834/4885RAB9A 3342/4885ALDH1A1 2122/4885 |
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | KRT18, KRTCAP2, CKAP4 | NPC1 4803/4885RAB9A 3564/4885ALDH1A1 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.